23 Miss. Code. R. 219-1.7 - Qualitative Drug Screening
A. Medicaid will
cover medically necessary qualitative drug screens for:
1. Suspected drug overdose, and one (1) or
more of the following conditions are present:
a) Unexplained coma,
b) Unexplained altered mental
status,
c) Severe or unexplained
cardiovascular instability, or cardiotoxicity,
d) Unexplained metabolic or respiratory
acidosis,
e) Unexplained head
trauma with neurological signs and symptoms, and/or
f) Seizures with an undetermined
history.
2.
Beneficiaries who present with clinical signs/symptoms of substance
abuse.
3. High risk pregnancy, only
when the documented patient history demonstrates that the procedure is
medically necessary. Medicaid does not consider a qualitative drug screen as a
routine component of assessment.
4.
EPSDT services, only when the documented patient history demonstrates that the
procedure is medically necessary. Medicaid does not consider a qualitative drug
screen as a routine component of assessment.
5. Beneficiaries who are locked into a
Beneficiary Health Management Program to assure compliance.
6. Beneficiaries prescribed certain
medications as part of a treatment plan that requires testing according the
Mississippi Board of Medical Licensure.
B. The appropriate procedure chemistry codes
must be used for quantitation of drug screens and procedure therapeutic drug
assays for therapeutic drug levels. All diagnosis codes must support medical
necessity for the drug screen.
C.
Non-covered Services:
1. Medicaid does not
cover qualitative drug screens for the following:
a) To screen for the same drug with both a
blood and a urine specimen simultaneously,
b) For legal purposes that are unrelated to
medical treatment and not medically necessary such as, but not limited to
screenings ordered by the court or law enforcement,
c) For employment purposes,
d) For the active treatment of substance
abuse, including monitoring for compliance, or
e) As a component of medical examination for
administrative purposes.
D. Documentation Requirements
1. The ordering/referring provider must
retain documentation supporting medical necessity in the medical record. All
tests must be ordered in writing, and all drugs/drug classes to be screened
must be indicated in the order. A copy of the lab results must be retained in
the medical record.
2. If the
provider rendering the service is other than the ordering/referring provider,
the provider rendering the service must maintain hard copy documentation of the
ordering/referring provider's order for the test and the lab results. The order
must include clinical indication/medical necessity in addition to all
drugs/drug classes to be screened.
3. Records must be documented and maintained
in accordance with Part 200, Chapter 1, Rule
1.3.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.